Singapore, Aug 26, 2009: Korean company, Bioneer is setting up Real Time Diagnostic system in 30 major university hospitals and four out of five major National Clinical Diagnostics Service Center in Korea. Bioneer is already said to have set up over 20 different locations of Health Centers more than 17 different locations of Health Centers and Environment Research Centers in South Korea.

 

AccuPower New Influenza A (H1N1) Real Time RT-PCR diagnostics kits is developed based on the patented Premix technology to maximize reproducibility and stability. The kit is ready-to-use lyophilized mixture that only needs to add extracted sample RNA into the tube. Within 90 minutes, the test result will confirm negative or positive. The kit was developed by using comprehensive alignment analysis of Influenza virus. According to the company, the system is composed of Exicycler 96, ExiPrep 16 and Exispin.

 

Bioneer is said to have released a total solution from sample prep to detection. It is designed to detect H1N1 virus accurately by selecting the variation which were classified between New Influenza A (H1N1) and the existing seasonal Influenza type A. The kit is validated and being supplied to major clinical service lab and hospital in South Korea.

 

The sample prep process of New Influenza A (H1N1) is said to be a very cautious step. Especially any possibility of aerosol generation or contact should be removed during the process. Bioneer’s ExiPrep 16 Automatic DNA/RNA Extractor can eliminate any possibilities of aerosol generation during the prep process.

 

AccuPower New Influenza A (H1N1) Real-Time RT-PCR kit is developed to run in Exicycler 96 Real-Time PCR which is CE-IVD and NEP Certified. Exicycler 96 Real-Time PCR has been awarded as superior technological system that has high sensitivity. Bioneer is now rapidly expanding total solution for Real-Time Diagnostic system not just in Korea, but also throughout Asia and Middle East.